In endometrial and ovarian cancers, the expression of TPI-1 and ENO1 was higher in metastatic tumors than in primary tumors; this finding was consistent with the reported role of these proteins in promoting tumor cell survival and proliferation [21, 22]. Here, ENO1 is linked to metastatic neoplasm.